Preoperative Mean Platelet Volume and Platelet Distribution Width Predict Postoperative Sepsis in Patients with Colorectal Cancer

Li, Xue-ting; Yan, Zibo; Wang, Rui-tao; Yu, Kai-jiang

doi:https://doi.org/10.1155/2019/9438750

BioMed Research International

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Clinical Study | Open Access

Volume 2019 | Article ID 9438750 | https://doi.org/10.1155/2019/9438750

Preoperative Mean Platelet Volume and Platelet Distribution Width Predict Postoperative Sepsis in Patients with Colorectal Cancer

Xue-ting Li,¹Zibo Yan,²Rui-tao Wang,^3,4and Kai-jiang Yu^4,5

Academic Editor: Raffaele Serra

Received24 Jul 2019

Accepted04 Oct 2019

Published30 Oct 2019

Abstract

Purpose. Mean platelet volume (MPV) and platelet distribution width (PDW) have been used to reflect the platelet activity in clinics. We assessed initial serum MPV and PDW levels in colorectal cancer (CRC) patients, in predicting the development of sepsis in CRC patients postoperatively. Patients and Methods. This study included 220 patients diagnosed with CRC. 55 patients were stratified to one group that developed sepsis postoperatively, and 165 patients were stratified to the other group that did not develop sepsis postoperatively. Clinical and laboratory characteristics were collected 3 days before the operation. Results. MPV () was significantly higher and PDW () was significantly lower in the sepsis group than in the nonsepsis group. Either MPV or PDW is independently associated with ICU mortality in sepsis patients with CRC. MPV is independently associated with 14-day, 28-day, and 90-day mortality and PDW is independently associated with 90-day mortality in patients with CRC. The prevalence of sepsis increased as MPV tertiles increased (), and the prevalence of sepsis increased as PDW tertiles decreased (). Conclusions. Serum MPV and PDW levels between CRC patients with/without sepsis postoperatively are significantly different. The initial serum MPV or PDW levels can potentially serve as a predictor of sepsis in CRC patients postoperatively.

1. Introduction

Cancer is the leading cause of high mortality worldwide and causes heavy socioeconomic impact [1–3]. Among cancer patients, death due to sepsis-related multiorgan failure is more frequent than death due to cancer itself [4–7]. Colorectal cancer (CRC) is one of the commonest malignant diseases in China and is a frequent cause of cancer-related death [8].

Sepsis is identified as life-threatening organ dysfunction caused by a dysregulated host response to infection [9]. The multiple organ failure caused by sepsis is the most lethal cause of surgery in ICU [10]. A study reported the mortality rate for cancer patients with septic shock admitted to the critical care unit (ICU) is nearly 54% [11].

It is well known that platelets are related to the hemostasis and coagulation function [12]. In recent years, more and more studies have confirmed that activated platelets are involved in the development and metastasis of tumors [13, 14]. Interaction between platelets and the tumor cells is not depending on the platelet quantity but on the volume and size because larger platelets have more granules and receptors [15]. Platelet volume indices have been used to reflect the platelet activity in clinics, including mean platelet volume (MPV) and platelet distribution width (PDW) [16]. MPV is found as an indicator of activated platelets and associated with many cancers [17–19]. PDW, another platelet parameter, indicates variation in platelet size and differentially diagnoses thrombocytopenia [16].

Even though more and more precaution was paid to hospitalized patients, sepsis incidence in cancer patients after surgery still takes up a significant burden of illness [20]. Patients undergoing surgery for CRC are at particular risk of sepsis because of underlying malignancy, being immunocompromised associated with cancer management and the complexity of surgical procedures performed [21]. Therefore, it is urgent to find out biomarkers which can predict the occurrence of postoperative sepsis in CRC patients. This study aimed to address the role of MPV and PDW as biomarkers in predicting the development of postoperative sepsis in CRC patients.

2. Patients and Methods

2.1. Study Design

This was a prospective study. The study protocol was approved by the Institutional Review Board of the Harbin Medical University Cancer Hospital. All patients signed informed consent.

2.2. Patients and Data Collection

CRC patients were admitted to the Harbin Medical University Cancer Hospital for surgery between January 1, 2015, and December 30, 2017. All patients underwent complete surgical resection, and the pathologic diagnoses were histologically confirmed by two experienced pathologists. There were 55 sepsis cases after surgery (mean age 63.4 ± 9.7 years, range 57–86 years). Using incidence density sampling, we matched the 55 sepsis patients with 165 controls by age, sex, and BMI (mean age 63.4 ± 9.0 years, range 46–78 years). All sepsis patients fulfilled the criteria of sepsis (SEPSIS-3) [22]. Cases were included if they met the following criteria: (1) age > 18 years; (2) patients who underwent complete surgical resection and diagnosis of CRC cancers being confirmed by histology; (3) diagnosis of sepsis after surgery in the intensive care unit (ICU); and (4) patients who did not receive preoperative chemotherapy or radiation therapy. Exclusion criteria included HIV infection, neutropenia (<500 neutrophils/mm³), and the medical treatment with steroids. The Acute Physiology and Chronic Health Evaluation (APACHE) II scores and the Sequential Organ Failure Assessment (SOFA) scores were determined.

2.3. Clinical Examination and Biochemical Measurements

All subjects underwent physical examination. Body mass index (BMI) was calculated as the ratio of weight (kg) to height squared (m²). Clinical data including medical history and medication use were recorded for each subject. Venous blood samples were collected 3 days before surgery. White blood cell (WBC), hemoglobin, and platelet indices were measured by an auto analyzer (Sysmex XE-2100, Kobe, Japan). The normal ranges of MPV and PDW in our hospital are 7–11 fL and 11–17%, respectively. The inter- and intra-assay coefficients of variation (CVs) of all these assays were below 5%.

2.4. Outcomes

The primary outcome of this study was to assess the predicting role of MPV and PDW in CRC patients who will be subjected to sepsis. Secondary outcomes were to certify if MPV or PDW can be a biomarker to forecast the ICU mortality or 28-day and 90-day mortality in sepsis patients with CRC.

2.5. Statistical Analysis

All statistical analyses were performed using SPSS Statistics version 22.0 (SPSS Inc., Chicago, IL, USA). The descriptive statistics are presented as means ± SD or medians (interquartile range) for continuous variables and percentages of the number for categorical variables. When baseline characteristics between two groups were compared, normally distributed continuous variables were compared with Student’s t-test and skewed-distributed with the Mann–Whitney U test. The chi-square test was used for categorical variables. The odds ratios (ORs) and 95% confidence intervals (95% CIs) for sepsis were calculated using conditional logistic regression analysis. was considered to indicate a statistically significant difference.

3. Results

The study cohort included a nonsepsis group () and a sepsis group (). The nonsepsis group included 99 men and 66 women. The sepsis group included 33 men and 22 women. Their characteristics are shown in Table 1; the mean age in the sepsis group is 63.4 ± 9.7 years, compared with the mean age of 63.4 ± 9.0 years in the nonsepsis group. There was no significant difference between the sepsis group and the nonsepsis group with regard to age, gender, body mass index (BMI), smoking, drinking, WBC, platelet count, creatinine, ALP, fibrinogen, CEA, and comorbidities. It was observed that hemoglobin, albumin, and PDW were significantly decreased in the sepsis group than in the nonsepsis group. However, MPV, LDH, APACHE II score, SOFA score, length of ICU stay, and ICU mortality were significantly increased in the sepsis group than in the nonsepsis group.

Conditional logistic regression analysis showed that albumin (HR, 0.883; CI, 0.829–0.940; ), MPV (HR, 2.125; CI, 1.677–2.694; ), and PDW (HR, 0.756; CI, 0.645–0.886; ) were independently associated with postoperative sepsis in CRC patients, as shown in Table 2. In addition, hemoglobin (HR, 1.029; CI, 1.002–1.057; ), albumin (HR, 0.884; CI, 0.805–0.970; ), MPV (HR, 1.841; CI, 1.369–2.476; ), and PDW (HR, 0.669; CI, 0.537–0.833; ) were independently associated with ICU mortality in sepsis patients with CRC, as shown in Table 3. Moreover, it is shown in Table 4 that albumin (HR, 0.842; CI, 0.772–0.917; ) and MPV (HR, 0.372; CI, 1.042–1.807; ) were independently associated with 28-day mortality. Albumin (HR, 0.867; CI, 0.809–0.929; ), MPV (HR, 1.626; CI, 1.309–2.019; ), and PDW (HR, 0.830; CI, 0.710–0.970; ) were independently associated with 90-day mortality in patients with CRC.

The association between MPV levels and the prevalence rate of sepsis (%) is shown in Figure 1. All the 220 participants (nonsepsis group + sepsis group) were stratified into tertiles according to their MPV levels. Tertile 1 (T1) was MPV ≤ 8.0 fL, tertile 2 (T2) was MPV 8.1–9.0 fL, and tertile 3 (T3) was MPV ≥ 9.1 fL. The prevalence rate of sepsis in T1, T2, and T3 was 8.75%, 18.31%, and 50.72%, respectively.

The association between PDW levels and the prevalence rate of sepsis (%) is shown in Figure 2. Participants were stratified into tertiles according to their PDW levels. Tertile 1 (T1) was PDW ≤ 16.5%, tertile 2 (T2) was PDW 16.6–17.4%, and tertile 3 (T3) was PDW ≥ 17.5%. The prevalence rate of sepsis in T1, T2, and T3 was 50.00%, 15.79%, and 8.57%, respectively.

4. Discussion

In this study, we found that elevated MPV levels or reduced PDW levels before surgery are associated with postoperative sepsis events. In addition, MPV or PDW was independently associated with ICU mortality in CRC patients. Moreover, MPV was independently associated with 14-day mortality, 28-day mortality, and 90-day mortality in CRC patients; meanwhile, PDW was independently associated with 90-day mortality in CRC patients.

The mechanisms to explain the association between preoperative MPV or PDW and postoperative sepsis events remain unclear. The MPV is on behalf of an average size of platelets. Increased MPV levels are involved in the mechanism of platelet activation [23]. PDW reflected the heterogeneity in platelet size. A high value of PDW suggests a large range of platelet size due to swelling, destruction, and immaturity [24]. PDW and MPV are common indices which are associated with platelet activation and function [25]. In our study, we observed the patients who developed postoperative sepsis have higher preoperative MPV levels but lower PDW levels. This is maybe due to the cancer-associated inflammation. Studies have shown that the original chronic inflammatory disease directly causes at least 20% of cancers, especially in colorectal cancer [26, 27]. More cytokines are generated during the inflammation course in cancer, such as IL-6 and IL-11, and highly upregulated in many cancers [28]. In addition, previous research confirmed that tumors could promote platelet production and activation through IL-6 signaling [29]. TLR2 is a toll-like receptor protein which is expressed on megakaryocytes and platelets and is involved in innate immune responses. Interactively, inflammation mediated platelet activation through cytokines [30].

Consistent with Li et al.’s study, elevated MPV levels in CRC patients predicted the worse outcomes [31]. One clinical study uncovered a phenomenon where there were increased MPV levels and the thrombocyte consumption in infections [32]. Cekmez et al. showed that the MPV levels have positive relation with the incidence of early sepsis [33]. A study of neonatal sepsis confirmed that patients with neonatal sepsis had high levels of MPV [34]. Orak et al. found high MPV levels were significant in terms of prognosis and mortality in sepsis patients [32]. In our study, the elevated MPV levels were associated with ICU mortality in CRC patients similar to those reported in other studies. Furthermore, we had firstly confirmed the predictive effect of preoperative MPV levels on postoperative patients with sepsis. However, Zhu et al. reported the change in PDW in colorectal cancer patients was significantly higher versus that in both colorectal adenoma patients and healthy participants [35]. Our conflicting data are maybe due to sepsis, small sample sizes, failure to exclude confounding factors, different tumor types, and selected populations. Therefore, further research is needed for PDW.

Our study has a few limitations: Firstly, our study is single-centered, and there were only 220 patients included. In addition, this study lacks mechanistic data to explain the role of MPV and PDW in the development of sepsis. Moreover, we only assessed the initial MPV and PDW levels, and we had no serial data. Time-dependent changes in MPV and PDW levels would be more valuable.

5. Conclusions

In conclusion, either increased MPV or decreased PDW is an independent predictor of postoperative sepsis after CRC surgery. Our data shed light on the value of MPV and PDW in sepsis prevention.

Data Availability

The clinical data of patients used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

The authors would like to express their deepest appreciation to all those who provided the possibility to complete this manuscript. This work was supported by the Harbin Medical University Cancer Hospital under Grant number JJZD2017-05.

References

J. D. Albano, E. Ward, A. Jemal et al., “Cancer mortality in the United States by education level and race,” JNCI: Journal of the National Cancer Institute, vol. 99, no. 18, pp. 1384–1394, 2007.
View at: Publisher Site | Google Scholar
J. Ferlay, D. M. Parkin, and E. Steliarova-Foucher, “Estimates of cancer incidence and mortality in Europe in 2008,” European Journal of Cancer, vol. 46, no. 4, pp. 765–781, 2010.
View at: Publisher Site | Google Scholar
G. H. Lim, K. Y. Chow, and H. P. Lee, “Singapore cancer trends in the last decade,” Singapore Medical Journal, vol. 53, no. 1, pp. 3–10, 2012.
View at: Google Scholar
G. T. Bird, P. Farquhar-Smith, T. Wigmore, M. Potter, and P. C. Gruber, “Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study,” British Journal of Anaesthesia, vol. 108, no. 3, pp. 452–459, 2012.
View at: Publisher Site | Google Scholar
F. I. Hawari, L. H. Nazer, A. Addassi, D. Rimawi, and K. Jamal, “Predictors of ICU admission in patients with cancer and the related characteristics and outcomes,” Critical Care Medicine, vol. 44, no. 3, pp. 548–553, 2016.
View at: Publisher Site | Google Scholar
V. Allareddy, S. Prakasam, V. Allareddy et al., “Poor oral health linked with increased risk of infectious complications in adults with leukemia,” Journal of the Massachusetts Dental Society, vol. 64, no. 3, pp. 38–42, 2015.
View at: Google Scholar
N. Obeng-Nkrumah, A.-K. Labi, M. E. Acquah, and E. S. Donkor, “Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting,” BMC Research Notes, vol. 8, no. 1, p. 742, 2015.
View at: Publisher Site | Google Scholar
J. Zhu, Z. Tan, K. Hollis-Hansen, Y. Zhang, C. Yu, and Y. Li, “Epidemiological trends in colorectal cancer in China: an ecological study,” Digestive Diseases and Sciences, vol. 62, no. 1, pp. 235–243, 2017.
View at: Publisher Site | Google Scholar
A. Rhodes, L. E. Evans, W. Alhazzani et al., “Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016,” Critical Care Medicine, vol. 45, no. 3, pp. 486–552, 2017.
View at: Publisher Site | Google Scholar
C. W. Seymour, F. Gesten, H. C. Prescott et al., “Time to treatment and mortality during mandated emergency care for sepsis,” New England Journal of Medicine, vol. 376, no. 23, pp. 2235–2244, 2017.
View at: Publisher Site | Google Scholar
C. J. Regazzoni, C. l. Irrazabal, C. M. Luna, and J. J. Poderoso, “Cancer patients with septic shock: mortality predictors and neutropenia,” Supportive Care in Cancer, vol. 12, no. 12, pp. 833–839, 2004.
View at: Publisher Site | Google Scholar
A. Osman, W. E. Hitzler, and P. Provost, “The platelets’ perspective to pathogen reduction technologies,” Platelets, vol. 29, no. 2, pp. 140–147, 2018.
View at: Publisher Site | Google Scholar
N. M. Bambace and C. E. Holmes, “The platelet contribution to cancer progression,” Journal of Thrombosis and Haemostasis, vol. 9, no. 2, pp. 237–249, 2011.
View at: Publisher Site | Google Scholar
H. A. Goubran, J. Stakiw, M. Radosevic, and T. Burnouf, “Platelet-cancer interactions,” Seminars in Thrombosis and Hemostasis, vol. 40, no. 3, pp. 296–305, 2014.
View at: Publisher Site | Google Scholar
J. F. Martin, P. M. W. Bath, and M. L. Burr, “Influence of platelet size on outcome after myocardial infarction,” The Lancet, vol. 338, no. 8780, pp. 1409–1411, 1991.
View at: Publisher Site | Google Scholar
K. Kaito, H. Otsubo, N. Usui et al., “Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia,” British Journal of Haematology, vol. 128, no. 5, pp. 698–702, 2005.
View at: Publisher Site | Google Scholar
Y. Kemal, G. Demirağ, K. Ekiz, and İ. Yücel, “Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer,” Journal of Obstetrics and Gynaecology, vol. 34, no. 6, pp. 515–518, 2014.
View at: Publisher Site | Google Scholar
S. Kilincalp, F. Ekiz, O. Başar et al., “Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer,” Platelets, vol. 25, no. 8, pp. 592–594, 2014.
View at: Publisher Site | Google Scholar
Y. Kumagai, S. Gilmour, E. Ota et al., “Estimating the burden of foodborne diseases in Japan,” Bulletin of the World Health Organization, vol. 93, no. 8, pp. 540–549C, 2015.
View at: Publisher Site | Google Scholar
A. Hiong, K. A. Thursky, B. W. Teh, G. M. Haeusler, M. A. Slavin, and L. J. Worth, “Sepsis following cancer surgery: the need for early recognition and standardised clinical care,” Expert Review of Anti-infective Therapy, vol. 14, no. 4, pp. 425–433, 2016.
View at: Publisher Site | Google Scholar
H. Brody, “Colorectal cancer,” Nature, vol. 521, no. 7551, p. S1, 2015.
View at: Publisher Site | Google Scholar
J. A. Russell, T. Lee, J. Singer, J. H. Boyd, and K. R. Walley, “The septic shock 3.0 definition and trials,” Critical Care Medicine, vol. 45, no. 6, pp. 940–948, 2017.
View at: Publisher Site | Google Scholar
J. Yang, X. Zhou, X. Fan et al., “mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation,” Blood, vol. 128, no. 5, pp. 615–624, 2016.
View at: Publisher Site | Google Scholar
Z. J. Ren, P.-W. Ren, B. Yang et al., “Mean platelet volume, platelet distribution width and platelet count in erectile dysfunction: a systematic review and meta-analysis,” Andrologia, vol. 49, no. 10, Article ID e12777, 2017.
View at: Publisher Site | Google Scholar
J. D. Eicher, G. Lettre, and A. D. Johnson, “The genetics of platelet count and volume in humans,” Platelets, vol. 29, no. 2, pp. 125–130, 2018.
View at: Publisher Site | Google Scholar
S. I. Grivennikov, K. Wang, D. Mucida et al., “Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth,” Nature, vol. 491, no. 7423, pp. 254–258, 2012.
View at: Publisher Site | Google Scholar
K. Wang, M. K. Kim, G. Di Caro et al., “Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis,” Immunity, vol. 41, no. 6, pp. 1052–1063, 2014.
View at: Publisher Site | Google Scholar
K. Taniguchi and M. Karin, “IL-6 and related cytokines as the critical lynchpins between inflammation and cancer,” Seminars in Immunology, vol. 26, no. 1, pp. 54–74, 2014.
View at: Publisher Site | Google Scholar
R. J. Lin, V. Afshar-Kharghan, and A. I. Schafer, “Paraneoplastic thrombocytosis: the secrets of tumor self-promotion,” Blood, vol. 124, no. 2, pp. 184–187, 2014.
View at: Publisher Site | Google Scholar
R. B. Undi, S. Sarvothaman, K. Narasaiah, U. Gutti, and R. K. Gutti, “Toll-like receptor 2 signalling: significance in megakaryocyte development through wnt signalling cross-talk and cytokine induction,” Cytokine, vol. 83, pp. 245–249, 2016.
View at: Publisher Site | Google Scholar
N. Li, Z. Yu, X. Zhang et al., “Elevated mean platelet volume predicts poor prognosis in colorectal cancer,” Scientific Reports, vol. 7, no. 1, p. 10261, 2017.
View at: Publisher Site | Google Scholar
M. Orak, Y. Karakoç, M. Ustundag, Y. Yildirim, M. K. Celen, and C. Güloglu, “An investigation of the effects of the mean platelet volume, platelet distribution width, platelet/lymphocyte ratio, and platelet counts on mortality in patents with sepsis who applied to the emergency department,” Nigerian Journal of Clinical Practice, vol. 21, no. 5, pp. 667–671, 2018.
View at: Publisher Site | Google Scholar
Y. Cekmez, M. Dizdar Güleçoğlu, C. Özcan, L. Karadeniz, and G. Kıran, “The utility of maternal mean platelet volume levels for early onset neonatal sepsis prediction of term infants,” Ginekologia Polska, vol. 88, no. 6, pp. 312–314, 2017.
View at: Publisher Site | Google Scholar
C. H. Patrick and J. Lazarchick, “The effect of bacteremia on automated platelet measurements in neonates,” American Journal of Clinical Pathology, vol. 93, no. 3, pp. 391–394, 1990.
View at: Publisher Site | Google Scholar
X. Zhu, Y. Cao, P. Lu et al., “Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer,” Scientific Reports, vol. 8, no. 1, p. 11814, 2018.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Xue-ting Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1287

Downloads

1146

Citations